With ministers eager to try to refashion the UK as a post-Brexit...

With ministers eager to try to refashion the UK as a post-Brexit hub for global life sciences, companies with drugs that promise to treat unmet medical needs will be offered help through the development process, including manufacturing, according to three people familiar with the situation.

Under the so-called Innovative Licensing and Access Pathway, companies are set to be offered the same rolling review of data that speeded approval of the Pfizer/BioNTech COVID-19 vaccine ahead of the rest of the world.

Interesting developments given we are at the University of Birmingham.